{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:27:57Z","timestamp":1791563277507,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060456"],"award-info":[{"award-number":["82060456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008111","name":"Hainan Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["SQ2025SLYZL0001"],"award-info":[{"award-number":["SQ2025SLYZL0001"]}],"id":[{"id":"10.13039\/501100008111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["821MS137"],"award-info":[{"award-number":["821MS137"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017944","name":"Hainan Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.gendis.2025.101810","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:51:42Z","timestamp":1755244302000},"page":"101810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Druggable target ATAD2 enhances the malignant progression and cooperates with E2F1 to up-regulate PDK1 expression in glioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Shenghua","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangwang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taixue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2794-2406","authenticated-orcid":false,"given":"Wen-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl 2","key":"10.1016\/j.gendis.2025.101810_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"issue":"10145","key":"10.1016\/j.gendis.2025.101810_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gendis.2025.101810_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.gendis.2025.101810_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","article-title":"Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers","volume":"45","author":"Salmaninejad","year":"2016","journal-title":"Immunol Investig"},{"issue":"10","key":"10.1016\/j.gendis.2025.101810_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.trecan.2018.08.005","article-title":"Emerging contributions of cancer\/testis antigens to neoplastic behaviors","volume":"4","author":"Gibbs","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.gendis.2025.101810_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","article-title":"Cause and consequence of cancer\/testis antigen activation in cancer","volume":"54","author":"Whitehurst","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101810_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188558","article-title":"Oncogenic cancer\/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy","volume":"1876","author":"Yang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.gendis.2025.101810_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2018.08.006","article-title":"Cancer-testis antigens: unique cancer stem cell biomarkers and targets for cancer therapy","volume":"53","author":"Gordeeva","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.gendis.2025.101810_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2022.102104","article-title":"Sperm-specific proteins: new implications for diagnostic development and cancer immunotherapy","volume":"77","author":"O'Donnell","year":"2022","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101810_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cells12060926","article-title":"Biology of cancer-testis antigens and their therapeutic implications in cancer","volume":"12","author":"Nin","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.gendis.2025.101810_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12672-024-01449-4","article-title":"Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma","volume":"15","author":"Zhuo","year":"2024","journal-title":"Discov Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101810_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7150\/thno.78840","article-title":"ATPase family AAA domain-containing protein 2 (ATAD2): from an epigenetic modulator to cancer therapeutic target","volume":"13","author":"Fu","year":"2023","journal-title":"Theranostics"},{"issue":"6559","key":"10.1016\/j.gendis.2025.101810_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1048","article-title":"Developmental chromatin programs determine oncogenic competence in melanoma","volume":"373","author":"Baggiolini","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.gendis.2025.101810_bib14","first-page":"2159","article-title":"Polo-like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101810_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom Proteom Bioinform"},{"issue":"6","key":"10.1016\/j.gendis.2025.101810_bib16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.gendis.2025.101810_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gendis.2025.101810_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/1541-7786.MCR-08-0435","article-title":"Rembrandt: helping personalized medicine become a reality through integrative translational research","volume":"7","author":"Madhavan","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"Database issue","key":"10.1016\/j.gendis.2025.101810_bib19","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2025.101810_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.gendis.2025.101810_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.gendis.2025.101810_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590861","article-title":"Clinical and biological significances of a ferroptosis-related gene signature in glioma","volume":"10","author":"Zhuo","year":"2020","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101810_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Software"},{"issue":"W1","key":"10.1016\/j.gendis.2025.101810_bib24","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2025.101810_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"issue":"D1","key":"10.1016\/j.gendis.2025.101810_bib26","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101810_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro Oncol"},{"issue":"D1","key":"10.1016\/j.gendis.2025.101810_bib28","doi-asserted-by":"crossref","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"41","key":"10.1016\/j.gendis.2025.101810_bib29","first-page":"1986","article-title":"Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging","author":"Ozawa","year":"2010","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.gendis.2025.101810_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201900397","article-title":"Inactivation of horseradish peroxidase by acid for sequential chemiluminescent western blot","volume":"15","author":"Han","year":"2020","journal-title":"Biotechnol J"},{"issue":"2","key":"10.1016\/j.gendis.2025.101810_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2264325","article-title":"Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma","volume":"55","author":"Zhuo","year":"2023","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.gendis.2025.101810_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.32604\/or.2024.045769","article-title":"Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of GNAL in glioma","volume":"32","author":"Liu","year":"2024","journal-title":"Oncol Res"},{"issue":"21","key":"10.1016\/j.gendis.2025.101810_bib33","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1158\/0008-5472.CAN-09-2131","article-title":"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors","volume":"69","author":"Cir\u00f3","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2025.101810_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/CMAR.S228629","article-title":"Knockdown of ATAD2 inhibits proliferation and tumorigenicity through the Rb-E2F1 pathway and serves as a novel prognostic indicator in gastric cancer","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101810_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13046-022-02412-3","article-title":"NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer","volume":"41","author":"Jing","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2025.101810_bib36","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.celrep.2016.08.018","article-title":"KDM4A coactivates E2F1 to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis","volume":"16","author":"Wang","year":"2016","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.gendis.2025.101810_bib37","first-page":"7002","article-title":"The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy","volume":"12","author":"Li","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.gendis.2025.101810_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119322","article-title":"Emerging oncogene ATAD2: signaling cascades and therapeutic initiatives","volume":"276","author":"Nayak","year":"2021","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101810_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/10409238.2021.1979460","article-title":"The AAA+ superfamily: a review of the structural and mechanistic principles of these molecular machines","volume":"57","author":"Khan","year":"2022","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"Pt 3","key":"10.1016\/j.gendis.2025.101810_bib40","article-title":"ATAD2 bromodomain in cancer therapy: current status and future perspectives","volume":"311","author":"Biju","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.gendis.2025.101810_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2019.11.008","article-title":"Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma","volume":"482","author":"Li","year":"2020","journal-title":"Cancer Lett"},{"issue":"24","key":"10.1016\/j.gendis.2025.101810_bib42","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-13-1868","article-title":"Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect","volume":"73","author":"Velpula","year":"2013","journal-title":"Cancer Res"},{"issue":"31","key":"10.1016\/j.gendis.2025.101810_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000677","article-title":"Metabolic modulation of glioblastoma with dichloroacetate","volume":"2","author":"Michelakis","year":"2010","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101810_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2008.02.001","article-title":"E2F1 in gliomas: a paradigm of oncogene addiction","volume":"263","author":"Alonso","year":"2008","journal-title":"Cancer Lett"},{"issue":"22","key":"10.1016\/j.gendis.2025.101810_bib45","doi-asserted-by":"crossref","first-page":"E5086","DOI":"10.1073\/pnas.1712363115","article-title":"Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma","volume":"115","author":"Xu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.gendis.2025.101810_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41419-021-03421-4","article-title":"The ATPase Pontin is a key cell cycle regulator by amplifying E2F1 transcription response in glioma","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.gendis.2025.101810_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/1541-7786.MCR-13-0459","article-title":"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance","volume":"12","author":"Zou","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.gendis.2025.101810_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2021.12.028","article-title":"Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase","volume":"528","author":"Haitani","year":"2022","journal-title":"Cancer Lett"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:51:46Z","timestamp":1772931106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225002995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2352304225002995"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101810","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Druggable target ATAD2 enhances the malignant progression and cooperates with E2F1 to up-regulate PDK1 expression in glioma","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101810"}}